Fund Holdings — Sarissa Capital Management LP

Total Portfolio Value:
$648.90M
Total Bought:
$51.41M
Total Sold:
$197.95M
Net Transaction:
-$146.54M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Ironwood Pharmaceuticals, Inc.CL A(IRWD)16,390,00016,390,0000$157.84M$187.50M28.90%+$29.67M
Biogen Inc.(BIIB)643,000643,0000$165.26M$166.39M25.64%+$1.13M
Innoviva, Inc.(INVA)7,277,0007,277,0000$94.53M$116.72M17.99%+$22.19M
Gilead Sciences, Inc.(GILD)920,4001,075,400+155,000$68.97M$87.12M13.43%+$18.14M
Neurocrine Biosciences, Inc.(NBIX)366,000470,000+104,000$41.17M$61.93M9.54%+$20.75M
Amarin Corp PlcADR10,442,45324,850,623+14,408,170$9.61M$21.62M3.33%+$12.01M
BioCryst Pharmaceuticals, Inc.(BCRX)775,0001,000,000+225,000$5.49M$5.99M0.92%+$503.0K
Vor Biopharma Inc.(VOR)618,000618,0000$1.31M$1.39M0.21%+$80.3K
Regulus Therapeutics Inc185,183185,1830$253.7K$237.0K0.04%-$16.7K
ALKERMES PLCSHS(ALKS)7,042,2000-7,042,200$197.25M$0—-$197.25M
MERSANA THERAPEUTICS INCCOM550,0000-550,000$698.5K$0—-$698.5K
Page 1 of 1
Sarissa Capital Management LP — 13F Holdings — Q4 2023 | TickerTrail